Mural Oncology PLC (MURA)
3.335
-0.04
(-1.04%)
USD |
NASDAQ |
Nov 22, 14:30
Mural Oncology Shareholders Equity (Quarterly): 174.14M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 174.14M |
| June 30, 2024 | 204.57M |
| March 31, 2024 | 234.93M |
| December 31, 2023 | 263.82M |
| Date | Value |
|---|---|
| September 30, 2023 | -6.892M |
| June 30, 2023 | 284.52M |
| December 31, 2022 | -21.66M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-21.66M
Minimum
Dec 2022
284.52M
Maximum
Jun 2023
161.92M
Average
204.57M
Median
Jun 2024
Shareholders Equity (Quarterly) Benchmarks
| Amarin Corp PLC | 531.38M |
| Jazz Pharmaceuticals PLC | 4.171B |
| Prothena Corp PLC | 534.36M |
| Iterum Therapeutics PLC | -6.15M |
| GH Research PLC | 189.37M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 203.27M |
| Total Liabilities (Quarterly) | 29.13M |